A promising study from Canada shows that some cannabis strains help reduce a specific type of inflammatory distress—called a “cytokine storm”—that proceeds severe cases of acute respiratory distress due to COVID-19.
The study found cannabis can reduce the severity of COVID-19. One of the main causes of severe COVID-19 that proceeds acute respiratory distress syndrome (ARDS) is an influx of “pro-inflammatory cytokines,” which is also known as the “cytokine storm.”
“As to specific chemicals, our analysis shows that CBD or THC alone do not have the same effect,” says Kovalchuck. “We strongly believe in the full-spectrum, entourage-based effects. Likely, there are secondary (minor cannabinoids) and terpenes that contribute, and we write in the paper, that one of such terpenes could be caryophyllene.”
The original article from Forbes and the link to the paper are here.